Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The purpose of the study is to evaluate the effect of real-time continuous glucose monitoring system on glucose control and outcomes of critically ill patients.
Real-time continuous glucose monitoring system has shown great accuracy and feasibility in critically ill patients. However, its impact on glucose control and outcomes has nearly unknown. Thus, Investigators designed this study to evaluate the effect of real-time continuous glucose monitoring system on glucose control and outcomes of critically ill patients.
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Continuous Glucose Monitoring Group | Experimental | Continuous Glucose Monitoring Group: Different methods of blood glucose monitoring between groups, and this group will use real-time continuous glucose monitoring system with alarm limits(high and low limit is 10 mmol/L and 8 mmil/L , respectively ) up to five days for glucose control, the target mean glucose level is between 8 and 10 mmol/L. |
|
| Conventional Group | Active Comparator | Conventional Group: Different methods of blood glucose monitoring between groups, and this group will use finger prick blood glucose measurements for glucose control with the same target mean glucose level of 8 -10 mmol/L. Patients also wear real-time continuous glucose monitoring system to collect glucose measurements. The values of real-time continuous glucose monitoring system are blinded to investigator and patients. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Different methods of blood glucose monitoring between groups | Other | Finger prick blood glucose in conventional group versus real-time continuous glucose monitoring system of continuous glucose monitoring group |
| Measure | Description | Time Frame |
|---|---|---|
| Glycemic Control Measures including: Percentage of target blood glucose levels (defined as between 8mmol/L and 10mmol/L); Time of hyperglycemia (defined as >10mmol/L); Hypoglycemia rate (defined as < 2.2mmol/L); Glucose lability index | Glycemic control measures will be assessed up to five days. |
| Measure | Description | Time Frame |
|---|---|---|
| Prognosis Measures including: Duration of mechanical ventilationï¼›Time of ICU stay; Time of hospital stay; 28 days - mortality rate | All the participants will be followed for the duration of hospital stay or 28 days. | |
| Cost | Cost associated with glucose monitoring |
Not provided
Inclusion Criteria:
More than 18 years old male or female;
Expected ICU stays longer than 72 hours;
Glucose level more than 8 mmol/L when enrolls in the ICU;
Exclusion Criteria:
Pregnant or lactating women;
ICU stays less than 72 hours;
Not provided
Not provided
Not provided
Not provided
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Yan Kang, MD | Contact | 86-028-85422508 | kang_yan_123@163.com | |
| Yan-yan Zuo, MM | Contact | 86-028-85422506 | zyyan21@163.com |
| Name | Affiliation | Role |
|---|---|---|
| Yan Kang, MD | West China Hospital | Study Director |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Intensive care unit of West China Hospital | Recruiting | Chengdu | Sichuan | 610000 | China |
Not provided
| ID | Term |
|---|---|
| D006943 | Hyperglycemia |
| D016638 | Critical Illness |
| ID | Term |
|---|---|
| D044882 | Glucose Metabolism Disorders |
| D008659 | Metabolic Diseases |
| D009750 | Nutritional and Metabolic Diseases |
| D020969 | Disease Attributes |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| D010335 | Pathologic Processes |
| D013568 | Pathological Conditions, Signs and Symptoms |